Tag: MSTX

CETV, VNDA, PHOT & Extended Watchlist

Central European Media Enterprises, Inc. CETV

We first caught CETV off of one of our From-4 scans back on May 10th. Time Warner had just purchased a block of shares worth close to $75M, and it caused us to take notice of the stock. At the time, we observed trades as low as 2.67.

As you can see on the chart below, CETV was on a fairly steady incline after that, recently (10/25) hitting a high of 6.60, a 147% move off of our observed bottom.

Shortly thereafter the stock would be subject to a big gap-down, and would continue to pull back to its current price in the low 2.00-range. The chart indicates that CETV is extremely oversold, and it has made higher lows over the past few sessions as it attempts to reverse its course. We want to keep our eyes peeled to this one, because conditions seem to be ripening for what could be a heck of a rebound.

Vanda Pharmaceuticals, Inc. VNDA

VNDA was a momentum play that we caught and included in yesterday’s extended watchlist. The company currently has a NDA (new drug application) filed with the FDA that treats chronic circadian arrhythmia.

After touching a low of 11.07 we saw a subsequent high of 13.49, a 22% intraday gain.

Growlife, Inc. PHOT

PHOT continues to be among our favorite medical/legal marijuana stocks, a play that we’ve followed for well over a year. Beginning at the end of August, trading at .0318, we realerted PHOT and began talking about it more and more.  We posted another reminder on the 16th of September, and once again on October 22nd, when we mentioned that a golden cross on the chart was imminent.

During yesterday’s session PHOT hit .1029, which marks a 224% increase off of the bottom we observed in late August. Even those who missed that report, could have caught the stock as low as .042 following the 09/16 reminder, for up to a 125% gain at yesterday’s high. From the third report we mentioned (10/22), significant gains to the tune of 43% from .0719-.1029 could have been achieved.

Extended Watchlist:
VDSC,  NURO, MSTX, FU, SUTR, YRCW(Huge gap down looking for reversal)
PBPB(Gapping up on positive earnings looking for continuation)

DCTH, ZLCS & Extended Watchlist

Delcath Systems, Inc.  DCTH
Following its inclusion in yesterday morning’s extended watchlist, DCTH would go on to have a massively successful day of trading. The stock, after briefly touching a bottom at the .402-mark, went on an absolute tear as it reached a high .66 around lunchtime.

A single-session gain of 64% on the first day we placed DCTH on our watchlist is certainly nothing to sneeze at, and given the circumstances behind the upward surge, that may have only been the beginning.

The company received word from the FDA that its Primary Liver Disease treatment, ChemoSat, had received “orphan drug” designation, a classification which denotes a drug or procedure that is aimed at a disease which affects less than 200,000 people. About 26,000 Americans are diagnosed with Primary Liver Disease each year.

(Thomson Reuters ONE via COMTEX) — New York, NY – October 1, 2013 – Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology, announced today that the U.S. Food & Drug Administration (FDA) has granted the Company orphan drug designation for melphalan in the treatment of patients with hepatocellular carcinoma (HCC, or primary liver cancer). >>>FULL STORY

Side Note:
We rarely see stocks in this price range with an active options chain, but DCTH is an exception. The 12/21 .50 Calls jump out at us at first glance. If the stock were to approach a dollar between now and the expiration date, one could be looking at triple-digit gains.

Zalicus, Inc. ZLCS

Coincidentally, ZLCS, a stock that we’ve been following since the beginning of last month, also received a recent FDA orphan drug designation for its experimental Z160 drug, intended for the treatment of pain related to the Shingles.

Hitting a high of 1.38 yesterday, we finally saw ZLCS fill the gap on the chart that we had been pointing out for some time. Since we’ve been following ZLCS, we’ve seen a low of .78, and yesterday’s high represents a 77% gain off of that bottom. The filling of that gap was a pretty good indicator that it was time to take profits off of the table, so we certainly hope that folks were able to take advantage.

This morning, they also announced a reverse split, the result of which should be the stocks continued listing on the Nasdaq Capital Market, as it should enable shares to remain above the 1.00 minimum bid price required for listing. We would expect shares to come away from this split valued in the $6.00-range, and sure enough, we are seeing trades go off as high as 6.45 pre-market.

Zalicus Inc. (Nasdaq Capital Market: ZLCS) today announced that it has filed a Certificate of Amendment to its Sixth Amended and Restated Certificate of Incorporation, with the Secretary of State of the State of Delaware to effect a 1-for-6 reverse stock split of Zalicus common stock, effective as of October 3, 2013 at 12:01 a.m. Eastern Time…The reverse stock split will reduce the number of shares of common stock issued and outstanding from approximately 147.5 million to approximately 24.6 million. >>> FULL STORY

Extended Watchlist:

VICL, CRRS, CIMT, MNTG, RNN, MSTX

IWEB, TCPS, NRBT, BCRX & Extended Watchlist

IceWEB, Inc. IWEB

We have continued to follow IWEB since our first report on the stock on Tuesday July 9th. We observed nearly 100% in cumulative gains from the stock that week. Next, we saw a pullback to our initial alert price (.024), followed by several days of higher highs and higher lows. In fact, IWEB has steadily built back to yesterday’s high of .034, which is just .0015 below the recent swing high of .0355.

We hope to see IWEB break through to the next level, as it tests its previous resistance. A move past .0355 could signal another breakout from this stock so we most definitely want to keep it on our radars moving forward. As we can see on the chart above, several indicators appear to be bullish.

In addition, BARCHART.COM is currently listing IWEB with a 72% Overall “Buy” Rating, and a 100% Short-term “Buy” Rating

More Info : http://www.iceweb.com/

SIDE NOTE:

For those who may have missed yesterday’s afternoon update, we had a few solid gainers come off of yesterday morning’s report, which included TCPS, NRBT, and BCRX. We’ll want to keep an eye on those symbols today as well.

Extended Watchlist:
OWOO, LQMT, CSE, MSTX, CBMX,